Quan Fang Selected Research

dansyl-prolyl-glutaminyl-argininamide

10/2007

Pharmacological effects of the dansylated neuropeptide FF analogues on body temperature and morphine analgesia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Quan Fang Research Topics

Disease

22	Pain (Aches) 02/2022 - 10/2002
11	Inflammation (Inflammations) 01/2022 - 05/2011
10	Myocardial Infarction 05/2015 - 04/2007
9	Atrial Fibrillation 07/2022 - 03/2005
8	Burns 01/2022 - 01/2015
8	Neoplasms (Cancer) 12/2021 - 07/2003
8	Pulmonary Arterial Hypertension 01/2021 - 08/2009
8	Thrombosis (Thrombus) 12/2018 - 12/2009
8	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016 - 11/2005
7	Hypertension (High Blood Pressure) 03/2022 - 06/2010
7	Heart Failure 01/2021 - 05/2008
6	Hyperalgesia 01/2022 - 10/2017
6	Wounds and Injuries (Trauma) 01/2021 - 04/2011
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2010
6	Atherosclerosis 08/2017 - 12/2010
5	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 04/2015
5	Amyloidosis 12/2017 - 03/2012
5	ST Elevation Myocardial Infarction 05/2015 - 01/2011
4	Cardiac Arrhythmias (Arrythmia) 07/2022 - 04/2008
4	Neuralgia (Stump Neuralgia) 01/2021 - 10/2018
4	Constipation 01/2021 - 10/2018
4	Postoperative Pain 08/2020 - 01/2018
4	Cardiomyopathies (Cardiomyopathy) 11/2019 - 04/2010
4	Hypothermia 06/2017 - 10/2007
4	Connective Tissue Diseases (Connective Tissue Disease) 03/2012 - 08/2009
4	Infarction (Infarctions) 11/2011 - 06/2010
3	Fibrosis (Cirrhosis) 07/2022 - 07/2016
3	Hypertrophy 01/2022 - 01/2013
3	Visceral Pain 08/2020 - 01/2018
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2019 - 01/2014
3	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 08/2014 - 10/2009
3	Obesity 11/2011 - 06/2010
3	Hyperlipidemias (Hyperlipidemia) 11/2011 - 06/2010
2	Hepatocellular Carcinoma (Hepatoma) 09/2022 - 07/2021
2	Hypoxia (Hypoxemia) 09/2022 - 12/2021
2	Atrial Flutter (Flutter, Atrial) 05/2022 - 03/2005
2	Facial Pain (Myofacial Pain) 02/2022 - 12/2018
2	Hypersensitivity (Allergy) 01/2022 - 01/2016
2	Ischemia 01/2022 - 05/2011
2	Infections 01/2021 - 01/2018
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2021 - 04/2010
2	Pulmonary Hypertension 01/2021 - 06/2011

Drug/Important Bio-Agent (IBA)

15	Opioid Analgesics (Opioids)IBA 07/2021 - 10/2007
14	phenylalanyl- leucyl- phenylalanyl- glutaminyl- prolyl- glutaminyl- arginyl- phenylalaninamideIBA 08/2020 - 10/2007
12	Analgesics (Analgesic Drugs)IBA 01/2022 - 12/2014
9	Formaldehyde (Formol)FDA Link 02/2022 - 12/2014
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2003
6	Biomarkers (Surrogate Marker)IBA 07/2022 - 11/2014
6	AntioxidantsIBA 01/2022 - 08/2007
6	Opioid Receptors (Opioid Receptor)IBA 08/2020 - 07/2008
6	neuropeptide FF receptorIBA 08/2020 - 07/2008
6	CannabinoidsIBA 01/2020 - 02/2014
6	omega-Chloroacetophenone (Mace)IBA 01/2016 - 06/2010
5	Biological ProductsIBA 01/2022 - 04/2015
5	Morphine (MS Contin)FDA LinkGeneric 08/2020 - 10/2007
5	CarrageenanIBA 03/2020 - 09/2013
5	Peptides (Polypeptides)IBA 01/2020 - 08/2014
4	astaxanthine (astaxanthin)IBA 01/2022 - 04/2015
4	EnzymesIBA 01/2022 - 03/2012
4	Urokinase Plasminogen Activator ReceptorsIBA 01/2016 - 02/2007
4	Adenosine (Adenocard)FDA LinkGeneric 08/2009 - 11/2005
3	Narcotic Antagonists (Opioid Antagonists)IBA 02/2022 - 10/2017
3	Heme Oxygenase-1IBA 01/2022 - 01/2021
3	CytokinesIBA 01/2022 - 01/2015
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 05/2011
3	p38 Mitogen-Activated Protein KinasesIBA 01/2022 - 11/2018
3	mu Opioid Receptors (mu Opioid Receptor)IBA 07/2021 - 11/2018
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2006
3	Acetic Acid (Vinegar)FDA LinkGeneric 08/2020 - 01/2018
3	Prealbumin (Transthyretin)IBA 11/2019 - 11/2016
3	7-(N-(3-aminopropyl)amino)heptan-2-oneIBA 11/2019 - 01/2014
3	Naloxone (Narcan)FDA LinkGeneric 01/2019 - 10/2017
3	AM 251 (AM251)IBA 01/2018 - 06/2017
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2017 - 08/2003
3	C-Reactive ProteinIBA 08/2017 - 03/2015
3	CaspasesIBA 01/2017 - 01/2015
3	CholesterolIBA 07/2015 - 01/2014
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 03/2015 - 12/2011
3	Vasodilator Agents (Vasodilators)IBA 01/2014 - 08/2009
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2012 - 02/2007
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2011 - 06/2010
2	ibutilide (Corvert)FDA LinkGeneric 05/2022 - 03/2005
2	ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA 01/2022 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2022
2	endomorphin 1IBA 07/2021 - 11/2018
2	SB 203580IBA 07/2021 - 11/2018
2	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 02/2011
2	Freund's AdjuvantIBA 08/2020 - 11/2018
2	TRPV1 receptorIBA 01/2020 - 01/2018
2	Amyloid (Amyloid Fibrils)IBA 11/2019 - 11/2016
2	endomorphin 2IBA 01/2019 - 11/2018

Therapy/Procedure

12	Therapeutics 01/2021 - 08/2003
12	Analgesia 03/2020 - 10/2007
12	Percutaneous Coronary Intervention 05/2015 - 11/2005
8	Stents 03/2015 - 07/2006
4	Catheter Ablation 07/2022 - 07/2013
4	Spinal Injections 01/2022 - 11/2018
4	Drug-Eluting Stents 12/2018 - 11/2011
2	Oral Administration 01/2021 - 01/2015
2	Subcutaneous Injections 01/2020 - 01/2020